Pharvaris N.V. (Public Offering)
Funding Details
Awarder
Inbox
Date Award
August 14, 2025
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount
$201,200,000
Company Info
Market
Bradykinin-mediated diseases
Location
Zug, Switzerland
Company Description

Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to potentially address all types of bradykinin-mediated angioedema.

Links
Website
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement